Please use this identifier to cite or link to this item:
http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/5521
Title: | Thiol Modification By Pharmacologically Active Agents of the Diazeniumdiolate Class |
Authors: | Maciag, Anna E. Holland, Ryan J. Saavedra, Joseph E. CHAKRAPANI, HARINATH Shami, Paul J. Keefer, Larry K. Dept. of Chemistry |
Keywords: | Thiol Nitric oxide Diazeniumdiolate 2012 |
Issue Date: | 2012 |
Publisher: | Begell |
Citation: | Onco Therapeutics, 3(2). |
Abstract: | Promising drug candidates of the diazeniumdiolate (NONOate) chemical family include several types of thiol modification among their mechanisms of action: 1) drugs designed to release nitric oxide (NO) on reaction with the thiol group of glutathione (GSH) arylate the GSH, a step that removes reducing equivalents from the cell; (2) a similar reaction of the drug with the thiol group of a protein changes its structure, leading to potentially impaired function and cell death; (3) the NO generated as a byproduct in the above reactions can undergo oxidation, leading to S-nitrosylation and S-glutathionylation; and (4) diazeniumdiolates can also generate nitroxyl, which reacts with thiol groups to form disulfides or sulfinamides. |
URI: | http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/5521 https://doi.org/10.1615/ForumImmunDisTher.2012006334 |
ISSN: | 2694-4642 2694-4650 |
Appears in Collections: | JOURNAL ARTICLES |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.